Latest One Wales decisions
- 24/05/2022
- Rituximab for pemphigus and pemphigoid (OW10)
-
-
-
Last review date: July 2023
- 12/04/2022
- Sorafenib for acute myeloid leukaemia (AML) maintenance (OW18)
-
-
-
Last review date: June 2023